Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review

References

• FinelliLMillerJTokarsJArduimoMNational surveillance of dialysis-associated diseases in the United StatesSemin Dial200518526115663766
   PubMed Web of Science ®Google Scholar
• FissellRBBragg-GreshamJLWoodsJDPatterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPSKidney Int2004652335234215149347
   PubMed Web of Science ®Google Scholar
• JadoulMPoignetJLGeddesCThe changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multi-centre studyNephrol Dial Transplant20041990490915031348
   PubMedGoogle Scholar
• WreghittTBlood–borne virus infections in dialysis units – a reviewRev Med Virol1999910110910386337
   PubMed Web of Science ®Google Scholar
• AmiriZShakibAToorchiMSeroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of IranEast Mediterr Health J20051137237616602456
   PubMedGoogle Scholar
• SypsaVPsichogiouMKatsoulidouAIncidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patientsAm J Kidney Dis20054533434315685512
   PubMedGoogle Scholar
• Kalantar-ZadehKKilpatrickRDMcAllisterCJHepatitis C virus and death risk in hemodialysis patientsJ Am Soc Nephrol2007181584159317429053
   PubMedGoogle Scholar
• NakayamaEAkibaTMarumoFSatoCPrognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapyJ Am Soc Nephrol2000111896190211004221
   PubMed Web of Science ®Google Scholar
• FabriziFMartinPDixitVBunnapradistSDulaiGMeta-analysis: effect of hepatitis C virus infection on mortality in dialysisAliment Pharmacol Ther2004201271127715606388
   PubMed Web of Science ®Google Scholar
• LegendreCGarrigueVLe BihanCHarmful long-term impact of hepatitis C virus infection in kidney transplant recipientsTransplantation1998656676709521201
   PubMed Web of Science ®Google Scholar
• MathurinPMouquetCPoynardTImpact of hepatitis B and C virus on kidney transplantation outcomeHepatology1999292572639862875
   PubMedGoogle Scholar
• FabriziFPoordadFMartinPHepatitis C infection and the patient with end stage renal diseaseHepatology20023631012085342
   PubMed Web of Science ®Google Scholar
• MartinPFabriziFHepatitis C virus and kidney diseaseJ Hepatol20084961362418662838
   PubMed Web of Science ®Google Scholar
• FabriziFLamperticoPLunghiGManganoSAucellaFMartinPReview article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantationAliment Pharmacol Ther20052162363215771749
   PubMed Web of Science ®Google Scholar
• SezerSOzdemirFAkcayAAratZBoyaciogluSHaberalMRenal transplantation offers a better survival in HCV-infected ESRD patientsClin Transplant20041861962315344970
   PubMed Web of Science ®Google Scholar
• Al-FreahMZeinoZHeneghanMManagement of hepatitis C in patients with chronic kidney diseaseCurr Gastroenterol Rep201214788622161023
   PubMedGoogle Scholar
• PatelPThompsonNKallenAArduinoMEpidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patientsAm J Kidney Dis20105637137820570422
   PubMed Web of Science ®Google Scholar
• TokarsJFrankMAlterMArduinoMNational surveillance of dialysis-associated diseases in the United States, 2000Semin Dial20021516217112100454
   PubMed Web of Science ®Google Scholar
• GoharSKhalilRElaishNKhedrEAhmedMPrevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipientsJ Egypt Public Health Assoc19957046548417214170
   PubMedGoogle Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO)KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney diseaseKidney Int Suppl2008Suppl 109S1S99
   Google Scholar
• [No authors listed]Recommendations for preventing transmission of infections among chronic hemodialysis patientsMMWR Recomm Rep200150143
   PubMedGoogle Scholar
• GordonCEUhligKLauJSchmidCHLeveyASWongJBInterferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment and efficacy and harmsAm J Kidney Dis20085126327718215704
   PubMed Web of Science ®Google Scholar
• LiuCHLiangCCHuangKWTransient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patientsClin J Am Soc Nephrol201161057106521393486
   PubMedGoogle Scholar
• FabriziFTakkoucheBLunghiGDixitVMessaPMartinPThe impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studiesJ Viral Hepat20071469770317875004
   PubMed Web of Science ®Google Scholar
• OkudaKYokosukaONatural history of chronic hepatitis C in patients on hemodialysis: case control study with 4–23 years of follow upWorld J Gastroenterol2004102209221215259067
   PubMed Web of Science ®Google Scholar
• TrevizoliJEde Paula MenezesRRibeiro VelascoLFHepatitis C is less aggressive in hemodialysis patients than in nonuremic patientsClin J Am Soc Nephrol200831385139018650408
   PubMed Web of Science ®Google Scholar
• FurusyoNHayashiJAriyamaIMaintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infectionAm J Gastroenterol20099549049610685756
   PubMedGoogle Scholar
• FabriziFDixitVMessaPImpact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?J Viral Hepat20121960160722863263
   PubMed Web of Science ®Google Scholar
• AzevedoHAVillela-NogueiraCAPerezRMSimilar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV infected with normal renal functionJ Nephrol20072060961617918148
   PubMed Web of Science ®Google Scholar
• FabriziFMessaPMartinPImpact of hemodialysis therapy on hepatitis C virus infection: a deeper insightInt J Artif Organs20093211119241358
   PubMed Web of Science ®Google Scholar
• RostaingLPeresCTkaczukJEx vivo flow cytometry determination of intracytoplasmic expression of IL-2, IL-6, IFN-gamma and TNF alpha in monocytes and T-lymphocytes in chronic hemodialysis patientsAm J Nephrol200020182610644863
   PubMedGoogle Scholar
• WangSMLiuHChouCHuangCShihCChenWMortality in hepatitis C-positive patients treated with peritoneal dialysisPerit Dial Int20082818318718332455
   PubMed Web of Science ®Google Scholar
• BloomRDLakeJREmerging issues in hepatitis C virus positive liver and kidney transplant recipientsAm J Transplant200662232223716869798
   PubMedGoogle Scholar
• MoralesJMAguadoJMHepatitis C and renal transplantationCurr Opin Organ Transplant20121760961523111646
   PubMed Web of Science ®Google Scholar
• RothDReddyKRKupinWLong-term impact of HCV on clinical outcomes and liver histology in kidney recipientsAm J Transplant2004A478289
   Google Scholar
• ParameshASDavisJYMallikarjunCKidney transplantation alone in ESRD patients with hepatitis C cirrhosisTransplantation20129425025422790385
   PubMedGoogle Scholar
• CamposSParsikiaAZakiRFOrtizJAKidney transplantation alone in ESRD patients with hepatitis C cirrhosisTransplantation2012946566
   Google Scholar
• JustaSMintzRMintzMSerial measurements of hepatitis C viral load by real-time polymerase chain reaction among recipients of living-donor renal transplants: a short-term follow-up study from a single centerTransplant Proc2010423568357321094817
   PubMed Web of Science ®Google Scholar
• RothDGaynorJReddyKEffect of kidney transplantation on outcomes among patients with hepatitis CJ Am Soc Nephrol2011221152116021546575
   PubMed Web of Science ®Google Scholar
• AlricLDi-MartinoVSelvesJLong-term impact of renal transplantation on liver fibrosis during hepatitis C virus infectionGastroenterology20021231494149912404224
   PubMed Web of Science ®Google Scholar
• ManuelOBaid-AgrawalSMoradpourDPascualMImmunosuppression in hepatitis C virus-infected patients after kidney transplantationContrib Nephrol2012769710722310785
   PubMedGoogle Scholar
• TothCPascualMChungRHepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapyTransplantation199866125412589825826
   PubMedGoogle Scholar
• SiddiquiARAbbasZLuckNHExperience of fibrosing cholestatic hepatitis with hepatitis C virus in kidney transplant recipientsTransplant Proc20124472172422483477
   PubMedGoogle Scholar
• CimsitBAssisDCaldwellCSuccessful treatment of fibrosing cholestatic hepatitis after liver transplantationTransplant Proc20114390590821486625
   PubMedGoogle Scholar
• StokesMImmune complex glomerulonephritis in patients with hepatitis CSaudi J Kidney Dis Transpl20001139640418209331
   PubMedGoogle Scholar
• Vallet-PichardAFontaineHMalletVPolSViral hepatitis in solid organ transplantation other than liverJ Hepatol20115547448221241754
   PubMedGoogle Scholar
• IngsathitAKamanamoolNThakkinstianASumethkulVSurvival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta analysisTransplantation20139594394823425817
   PubMed Web of Science ®Google Scholar
• EspinosaMMartin-MaloAAlvarez de LaraMARisk of death and liver cirrhosis in anti-HCV-positive long term hemodialysis patientsNephrol Dial Transplant2001161669167411477172
   PubMed Web of Science ®Google Scholar
• SolezKColvinRBRacusenLCBanff´05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN’)Am J Transplant2007751852617352710
   PubMed Web of Science ®Google Scholar
• FabriziFDixitVMessaPMartinPInterferon monotherapy of chronic hepatitis C in patients: meta-analysis of clinical trialsJ Viral Hepat200815798818184190
   PubMed Web of Science ®Google Scholar
• ChanTWuPLauJLokALaiCChengIInterferon treatment for hepatitis C virus infection in patients on haemodialysisNephrol Dial Transplant199712141414199249778
   PubMed Web of Science ®Google Scholar
• LiuCLiangCLinJPegylated interferon alpha 2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised studyGut20085752553017881538
   PubMed Web of Science ®Google Scholar
• GordonCUhligKLauJSchmidCLeveyAWongJInterferon for hepatitis C virus in hemodialysis – an individual patient meta-analysis of factors associated with sustained virological responseClin J Am Soc Nephrol200941449145819643927
   PubMed Web of Science ®Google Scholar
• CovicAMafteiIMardareNAnalysis of safety and efficacy of PEGylated interferon alpha 2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter auditJ Nephrol20061979480117173254
   PubMed Web of Science ®Google Scholar
• WangKLXingHQZhaoHEfficacy and tolerability of low dose interferon-α in hemodialysis patients with chronic hepatitis C virus infectionWorld J Gastroenterol2014204071407524744598
   PubMed Web of Science ®Google Scholar
• FabriziFDixitVMessaPMartinPInterferon monotherapy of chronic hepatitis C in patients: meta-analysis of clinical trialsJ Viral Hepat200815798818184190
   PubMed Web of Science ®Google Scholar
• LiuCLiangCLinJPegylated interferon alpha-2a versus standard interferon alpha-2a for treatment naive dialysis patients with chronic hepatitis C: a randomised studyGut20085752553017881538
   PubMed Web of Science ®Google Scholar
• BruchfeldAStahleLAnderssonJSchvarezRRibavirin treatment in dialysis patients with chronic hepatitis C virus infection – a pilot studyJ Viral Hepat2001828729211454181
   PubMed Web of Science ®Google Scholar
• TanABrouwerJGluePSafety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot studyNephrol Dial Transplant20011619319511209032
   PubMed Web of Science ®Google Scholar
• MousaDAbdallaAAl-ShoailGAl-SulaimanMAl-HawasFAl-KhaderAAlpha interferon with ribavirin in the treatment of hemodialysis patients with hepatitis CTransplant Proc2004361831183415350490
   PubMed Web of Science ®Google Scholar
• FabriziFDixitVMartinPMessaPCombined antiviral therapy of hepatitis C virus in dialysis patients: meta analysis of clinical trialsJ Viral Hepat201118e253e269
   Web of Science ®Google Scholar
• RendinaMSchenaACastellanetaNThe treatment of chronic hepatitis C with peginterferon alfa 2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplantJ Hepatol20074676877417383045
   PubMed Web of Science ®Google Scholar
• DjordjevićVKostićSStefanovićVTreatment of chronic hepatitis C with interferon alpha in patients on maintenance hemodialysisNephron1998792292319647511
   PubMed Web of Science ®Google Scholar
• LiuCLiangCLiuCPegylated interferon alfa 2 plus low dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapyGut20095831431619136527
   PubMed Web of Science ®Google Scholar
• HassanQRocheBBuffetCLiver-kidney recipient with chronic viral hepatitis C treated with interferon-alphaTranspl Int20122594194722882335
   PubMed Web of Science ®Google Scholar
• Al-HarbiAMalikGSubaityYMansyHAbutalebNTreatment of acute hepatitis C virus infection with alpha interferon in patients with hemodialysisSaudi J Kidney Dis Transpl20051629329717642795
   PubMedGoogle Scholar
• FabriziFDixitVMessaPMartinPInterferon therapy of acute hepatitis C in dialysis patients: meta-analysisJ Viral Hepat20121978479123043385
   PubMed Web of Science ®Google Scholar
• KamarNToupanceOBuchlerMSandres-SauneKIzopetJDurandDEvidence that clearance of hepatitis C virus RNA after interferon therapy in dialysis patients in sustained after renal transplantationJ Am Soc Nephrol2003122092209812874463
   PubMedGoogle Scholar
• RothDBloomRSelection and management of hepatitis C-virus infected patients for the kidney transplant waiting listContrib Nephrol2012176667622310782
   PubMed Web of Science ®Google Scholar
• HassanQRocheBBuffetCSessadeTSamuelDCharpentierBDurrbachALiver-kidney recipient with chronic viral hepatitis C treated with interferon-alphaTranspl Int20122594194722882335
   PubMed Web of Science ®Google Scholar
• WeiFLiuFHuHRenHHuPInterferon based antiviral therapy for hepatitis C virus infection after renal transplantation: an update meta-analysisPLoS One20149111
   Web of Science ®Google Scholar
• GargVvan HeeswijkRLeeJEAlvesKNadkarniPLuoXThe effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimusHepatology201154202721618566
   PubMed Web of Science ®Google Scholar
• WoodsideKJIdshiharaKTheisenJEUse of kidneys from hepatitis C seropositive donors shortens waitlist time but does not alter one-yr outcomeClin Transplant20031743343714703926
   PubMed Web of Science ®Google Scholar
• KucirkaLMSingerALRosRAUnderutilization of hepatitis C-positive kidneys for hepatitis C positive recipientsAm J Transplant2010101238124620353475
   PubMed Web of Science ®Google Scholar
• KucirkaLMPetersTGSegevDLImpact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipientsAm J Kidney Dis20126011212022560841
   PubMed Web of Science ®Google Scholar
• MoralesJMCampistolJMDomínguez-GilBLong term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipientsAm J Transplant2010102453246220977636
   PubMedGoogle Scholar
• MoralesJMCampistolJMCastellanoGTransplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCVKidney Int1995472362407537343
   PubMed Web of Science ®Google Scholar
• VerouxPVerouxMSparacinoVKidney transplantation from donors with viral B and C hepatitisTransplant Proc20063899699816757242
   PubMed Web of Science ®Google Scholar
• NatovSNLauJYRuthazerRSchmidCHLeveyASPereiraBJHepatitis C virus genotype does not affect patient survival among renal transplant candidates. The New England Organ Bank Hepatitis C Study GroupKidney Int19995670070610432411
   PubMed Web of Science ®Google Scholar
• TreitelMMarburyTPrestonRASingle-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal functionClin Pharmacokinet20125161962822799589
   PubMed Web of Science ®Google Scholar
• DurmortierJGuillaudOGagnieuMCAnti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?J Clin Virol20135614614923149155
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationSovaldi prescribing information2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/205123Orig1s000ClinPharmR.pdfAccessed July 16, 2014
   Google Scholar
• Sovaldi (sofosvubir) [package insert]Foster City, CA, USAGilead Sciences, Inc2013
   Google Scholar
• GhanyMNelsonDStraderDThomasDSeeffLAn update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guidelines by the American Association for the Study of Liver DiseasesHepatology2011541433144421898493
   PubMed Web of Science ®Google Scholar
• GordonCEBalkEMBeckerBNKDOQI US Commentary on the KDIGO clinical practice guideline for the prevention diagnosis, evaluation, and treatment of hepatitis C in CKDAm J Kidney Dis200852815825
   Web of Science ®Google Scholar